Vitrafy Life Sciences (VFY) Collaboration summary

Opening remarks and agenda

• Announced a 12-month exclusive strategic commercial agreement to integrate next-generation cryopreservation technology with IMV's global offering, marking a significant step in commercialisation strategy for immediate revenue and long-term growth.

Objectives of the partnership

• Integrate cryopreservation technology with a global animal reproduction product suite to set a new industry benchmark and accelerate access to the animal market at scale.

• Jointly commercialise a global cryopreservation solution for farm animals and aquaculture, enabling global market access and supporting expansion into the human health market in North America.

• Validate the technology in a commercial setting and leverage partner expertise.

Partner introductions and roles

• IMV Technologies is a French-based multinational, global leader in animal reproductive technologies, supporting over 500 million inseminations annually and present in 128 countries.

• Vitrafy provides next-generation cryopreservation technology, supplying devices, software, and support for integration and pre-commercialisation activities.